A comprehensive view of boston scientific corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Company reveals Q2 earnings; key outcomes draw investor attention

BSX to Present Q2 2024 Financial Results in Webcast Tomorrow; detailed discussion on financial milestones

Boston Scientific reports $4.12 billion in Q2 2024 net sales, growing 14.5%; GAAP net income hits $324 million, $0.22 per share, adjusted EPS reaches $0.62

US Patent Issued to Boston Scientific Neuromodulation on July 23 for "Implantable device programming management" (California Inventors)

US Patent Issued to Boston Scientific Neuromodulation on July 23 for "System to estimate the location of a spinal cord physiological midline" (California Inventors)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count